Highlighted transactions

Healthcare

 

Integra LifeSciences

Piper Jaffray served as exclusive financial advisor to Integra LifeSciences on separation of its orthobiologics and spinal fusion hardware business (SeaSpine) in the form of a tax-free dividend involving the distribution of all outstanding shares of SeaSpine common stock to holders of Integra common stock.

Client Description

Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedics, neurosurgery, reconstructive and general surgery.

Counterparty Description

SeaSpine is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The company has a comprehensive portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine.

Back